INSYS Therapeutics Reports Third Quarter 2017 Results
November 02, 2017 06:00 ET
|
Insys Therapeutics, Inc.
PHOENIX, Nov. 02, 2017 (GLOBE NEWSWIRE) -- INSYS Therapeutics, Inc. (NASDAQ:INSY) (“INSYS” or “the company”), today reported financial results for its third quarter ended Sept. 30, 2017. OVERALL...
INSYS Therapeutics Provides Update on NASDAQ Trading Hold
October 30, 2017 10:09 ET
|
Insys Therapeutics, Inc.
PHOENIX, Oct. 30, 2017 (GLOBE NEWSWIRE) -- INSYS Therapeutics, Inc. (NASDAQ:INSY) (“INSYS” or “the company”), subsequent to the trading hold placed on its stock on Thursday after market close,...
INSYS Therapeutics to Record a Minimum Liability for Department of Justice Settlement in Q3 2017
October 29, 2017 20:45 ET
|
Insys Therapeutics, Inc.
PHOENIX, Oct. 29, 2017 (GLOBE NEWSWIRE) -- INSYS Therapeutics, Inc. (NASDAQ:INSY) (“INSYS” or “the company”), today made the following statement about the Department of Justice (DOJ) investigation. ...
INSYS Therapeutics Affirms Its Commitment to Sustainable Future Growth
October 29, 2017 20:00 ET
|
Insys Therapeutics, Inc.
PHOENIX, Oct. 29, 2017 (GLOBE NEWSWIRE) -- INSYS Therapeutics, Inc. (NASDAQ:INSY) (“INSYS” or “the company”), today released the following statement from its president and chief executive officer,...
INSYS Therapeutics Announces Resignation of Patrick P. Fourteau from Board of Directors
October 29, 2017 19:30 ET
|
Insys Therapeutics, Inc.
PHOENIX, Oct. 29, 2017 (GLOBE NEWSWIRE) -- INSYS Therapeutics, Inc. (NASDAQ:INSY) (“INSYS” or “the company”) today accepted the resignation of Patrick P. Fourteau from its Board of Directors...
INSYS Therapeutics Founder Dr. John N. Kapoor Steps Down from Board of Directors
October 29, 2017 18:30 ET
|
Insys Therapeutics, Inc.
PHOENIX, Oct. 29, 2017 (GLOBE NEWSWIRE) -- INSYS Therapeutics, Inc. (NASDAQ:INSY) (“INSYS” or “the company”) today accepted the resignation of the company’s founder, Dr. John N. Kapoor, from its...
INSYS Therapeutics to Report Third Quarter 2017 Results on Nov. 2
October 19, 2017 06:00 ET
|
Insys Therapeutics, Inc.
PHOENIX, Oct. 19, 2017 (GLOBE NEWSWIRE) -- INSYS Therapeutics, Inc. (NASDAQ:INSY) (“INSYS” or “the company”), today announced that it will release its third quarter 2017 financial results on...
INSYS Therapeutics, Inc. to Participate in Oppenheimer Specialty Pharma Summit
October 09, 2017 12:00 ET
|
Insys Therapeutics, Inc.
PHOENIX, Oct. 09, 2017 (GLOBE NEWSWIRE) -- INSYS Therapeutics, Inc. (NASDAQ:INSY) (“INSYS” or “the company”) announced today that Saeed Motahari, president and chief executive officer, and Andrew...
INSYS Therapeutics Extends ‘Compassionate Use’ Studies of Cannabidiol (CBD) for Refractory Pediatric Epilepsy
October 09, 2017 09:00 ET
|
Insys Therapeutics, Inc.
PHOENIX, Oct. 09, 2017 (GLOBE NEWSWIRE) -- INSYS Therapeutics, Inc. (NASDAQ:INSY) (“INSYS” or “the company”), announced today that it has extended the compassionate use studies of its proprietary...
INSYS Therapeutics Addresses New Jersey Complaint
October 06, 2017 09:00 ET
|
Insys Therapeutics, Inc.
PHOENIX, Oct. 06, 2017 (GLOBE NEWSWIRE) -- INSYS Therapeutics, Inc. (NASDAQ:INSY) (“INSYS” or “the Company”) today released the following statement: We would like to reiterate that we continue to...